BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 34016721)

  • 61. Structure and function of natural killer cell surface receptors.
    Radaev S; Sun PD
    Annu Rev Biophys Biomol Struct; 2003; 32():93-114. PubMed ID: 12471063
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Natural killer cell acceptance of H-2 mismatch bone marrow grafts in transgenic mice expressing HLA-Cw3 specific killer cell inhibitory receptor.
    Cambiaggi A; Verthuy C; Naquet P; Romagné F; Ferrier P; Biassoni R; Moretta A; Moretta L; Vivier E
    Proc Natl Acad Sci U S A; 1997 Jul; 94(15):8088-92. PubMed ID: 9223319
    [TBL] [Abstract][Full Text] [Related]  

  • 63. HLA-C levels impact natural killer cell subset distribution and function.
    Sips M; Liu Q; Draghi M; Ghebremichael M; Berger CT; Suscovich TJ; Sun Y; Walker BD; Carrington M; Altfeld M; Brouckaert P; De Jager PL; Alter G
    Hum Immunol; 2016 Dec; 77(12):1147-1153. PubMed ID: 27521484
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Recognition of peptide-MHC class I complexes by activating killer immunoglobulin-like receptors.
    Stewart CA; Laugier-Anfossi F; Vély F; Saulquin X; Riedmuller J; Tisserant A; Gauthier L; Romagné F; Ferracci G; Arosa FA; Moretta A; Sun PD; Ugolini S; Vivier E
    Proc Natl Acad Sci U S A; 2005 Sep; 102(37):13224-9. PubMed ID: 16141329
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.
    de Arias AE; Haworth SE; Belli LS; Burra P; Pinzello G; Vangeli M; Minola E; Guido M; Boccagni P; De Feo TM; Torelli R; Cardillo M; Scalamogna M; Poli F
    Liver Transpl; 2009 Apr; 15(4):390-9. PubMed ID: 19326408
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Influenza Virus Targets Class I MHC-Educated NK Cells for Immunoevasion.
    Mahmoud AB; Tu MM; Wight A; Zein HS; Rahim MM; Lee SH; Sekhon HS; Brown EG; Makrigiannis AP
    PLoS Pathog; 2016 Feb; 12(2):e1005446. PubMed ID: 26928844
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Natural killer cell recognition of HLA class I molecules.
    Brooks AG; Boyington JC; Sun PD
    Rev Immunogenet; 2000; 2(3):433-48. PubMed ID: 11256749
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Killer immunoglobulin-like receptors.
    Moretta L; Moretta A
    Curr Opin Immunol; 2004 Oct; 16(5):626-33. PubMed ID: 15342010
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Soluble HLA class I induces NK cell apoptosis upon the engagement of killer-activating HLA class I receptors through FasL-Fas interaction.
    Spaggiari GM; Contini P; Dondero A; Carosio R; Puppo F; Indiveri F; Zocchi MR; Poggi A
    Blood; 2002 Dec; 100(12):4098-107. PubMed ID: 12393468
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Inhibitory KIR/HLA incompatibility between sexual partners confers protection against HIV-1 transmission.
    Jennes W; Verheyden S; Mertens JW; Camara M; Seydi M; Dieye TN; Mboup S; Demanet C; Kestens L
    Blood; 2013 Feb; 121(7):1157-64. PubMed ID: 23243280
    [TBL] [Abstract][Full Text] [Related]  

  • 71. N-linked carbohydrate on human leukocyte antigen-C and recognition by natural killer cell inhibitory receptors.
    Baba E; Erskine R; Boyson JE; Cohen GB; Davis DM; Malik P; Mandelboim O; Reyburn HT; Strominger JL
    Hum Immunol; 2000 Dec; 61(12):1202-18. PubMed ID: 11163076
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Frequency of killer cell immunoglobulin-like receptors (KIRs) in Korean patients with chronic HCV infection.
    Sung PS; Choi HB; Kim SY; Hong SW; Park CH; Song MJ; Lee SW; Yoo CR; Choi SW; Han NI; Kim TG; Yoon SK
    J Korean Med Sci; 2011 Nov; 26(11):1483-8. PubMed ID: 22065905
    [TBL] [Abstract][Full Text] [Related]  

  • 73. HLA-C matching status does not affect rituximab-mediated antibody-dependent cellular cytotoxicity by allogeneic natural killer Cells.
    Machino T; Okoshi Y; Miyake Y; Akatsuka Y; Chiba S
    Immunol Invest; 2012; 41(8):831-46. PubMed ID: 22676066
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Killer Ig-like receptor ligand mismatch directs NK cell expansion in vitro.
    Rose MJ; Brooks AG; Stewart LA; Nguyen TH; Schwarer AP
    J Immunol; 2009 Oct; 183(7):4502-8. PubMed ID: 19748981
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The proinflammatory cytokines IL-2, IL-15 and IL-21 modulate the repertoire of mature human natural killer cell receptors.
    de Rham C; Ferrari-Lacraz S; Jendly S; Schneiter G; Dayer JM; Villard J
    Arthritis Res Ther; 2007; 9(6):R125. PubMed ID: 18053164
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Natural killer cell crossmatch: functional analysis of inhibitory killer immunoglobulin-like receptors and their HLA ligands.
    Han M; Fallena M; Guo Y; Stastny P
    Hum Immunol; 2007 Jun; 68(6):507-13. PubMed ID: 17509450
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Natural killer cells and their receptors.
    Middleton D; Curran M; Maxwell L
    Transpl Immunol; 2002 Aug; 10(2-3):147-64. PubMed ID: 12216946
    [TBL] [Abstract][Full Text] [Related]  

  • 78. KIR2DS1-mediated activation overrides NKG2A-mediated inhibition in HLA-C C2-negative individuals.
    Foley B; De Santis D; Lathbury L; Christiansen F; Witt C
    Int Immunol; 2008 Apr; 20(4):555-63. PubMed ID: 18308713
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Synergistic inhibition of natural killer cells by the nonsignaling molecule CD94.
    Cheent KS; Jamil KM; Cassidy S; Liu M; Mbiribindi B; Mulder A; Claas FH; Purbhoo MA; Khakoo SI
    Proc Natl Acad Sci U S A; 2013 Oct; 110(42):16981-6. PubMed ID: 24082146
    [TBL] [Abstract][Full Text] [Related]  

  • 80. DNGR-1 limits Flt3L-mediated antitumor immunity by restraining tumor-infiltrating type I conventional dendritic cells.
    Cueto FJ; Del Fresno C; Brandi P; Combes AJ; Hernández-García E; Sánchez-Paulete AR; Enamorado M; Bromley CP; Gomez MJ; Conde-Garrosa R; Mañes S; Zelenay S; Melero I; Iborra S; Krummel MF; Sancho D
    J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 33980589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.